Evidence map›Paper›PMID 35229618›Full record

ArticleJournal of the American Heart Association2022

Synergistic Effect of Uroguanylin and D

Cindy Zeng, Tianyang Xia, Shuo Zheng, Lijia Liang, Yue Chen

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Cindy ZengDepartment of Cardiology of Chongqing General Hospital Cardiovascular Research Center of Chongqing CollegeUniversity of Chinese Academy of Sciences Chongqing P. R. China.
Tianyang XiaDepartment of Cardiology, Daping Hospital The Third Military Medical University Chongqing P. R. China.ORCID 0000-0003-3363-036X
Shuo ZhengDepartment of Cardiology, Daping Hospital The Third Military Medical University Chongqing P. R. China.
Lijia LiangDepartment of Cardiology of Chongqing General Hospital Cardiovascular Research Center of Chongqing CollegeUniversity of Chinese Academy of Sciences Chongqing P. R. China.
Yue ChenDepartment of Cardiology, Daping Hospital The Third Military Medical University Chongqing P. R. China.ORCID 0000-0002-4403-9930
Army Medical University · CNUniversity of Chinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Oral NaCl produces a greater natriuresis and diuresis than the intravenous infusion of the same amount of NaCl, indicating the existence of a gastro-renal axis. As one of the major natriuretic hormones secreted by both the intestines and the kidney, we hypothesized that renal uroguanylin interacts with dopamine receptors to increase sodium excretion synergistically, an impaired interaction of which may be involved in the pathogenesis of hypertension. Methods and Results In Wistar-Kyoto rats, the infusion of uroguanylin or fenoldopam (a D

Indexed as

FenoldopamHypertensionNatriuretic PeptidesReceptors, Dopamine D1AnimalsKidneyKidney Tubules, ProximalNatriuresisRatsRats, Inbred SHRRats, Inbred WKYSodiumSodium ChlorideFenoldopamNatriuretic PeptidesReceptors, Dopamine D1SodiumSodium Chlorideuroguanylindopamine receptorhypertensionkidneyuroguanylin

Identifiers

PMID35229618
PMCPMC9075328
OpenAlexW4214522861

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.